[Clinical and experimental studies of the mechanism of neuroendocrine action of cerebral phospholipids: the behavior of prolactin as a marker of such action].
D000236:Adenoma / Q000378:metabolism; D000328:Adult; D005260:Female; D006801:Humans; D008081:Liposomes / Q000008:administration & dosage*; D008297:Male; D008787:Metoclopramide / Q000494:pharmacology; D008875:Middle Aged; D010743:Phospholipids / Q000494:pharmacology*; D010911:Pituitary Neoplasms / Q000378:metabolism; D011388:Prolactin / Q000097:blood*; D013469:Sulpiride / Q000494:pharmacology; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology
D008081:Liposomes; D010743:Phospholipids; D013973:Thyrotropin-Releasing Hormone; D013469:Sulpiride; D011388:Prolactin; D008787:Metoclopramide
Studi clinici e sperimentali sul meccanismo di azione neuroendocrino dei fosfolipidi cerebrali: il comportamento della prolattina quale marker di tale azione.